A Cost Analysis of Implementing Asynchronous Video Directly Observed Therapy for Monitoring Treatment in Patients with Tuberculosis Disease in Uganda
Preprint
- 21 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Video directly observed treatment (VDOT) supports person-centered care and addresses shortcomings of in-person directly observed treatment (DOTS). However, there is limited literature on implementation costs to inform TB program policy in low-resource settings, such as Uganda. Objective This study aimed to assess the costs associated with implementing the VDOT intervention in Uganda, based on a completed randomized trial. Methods We carried out a micro-costing analysis. This employed both bottom-up and top-down approaches to estimate health system costs (in 2024 US dollars) of the VDOT intervention. The analysis covered 71 persons with TB from six health facilities in Kampala, Uganda. Results The estimated overall costs for implementing VDOT in Uganda were $16,037.80 among 71 patients with TB. The estimated per-person costs for VDOT were $220.93. The largest proportion of the overall cost was associated with smartphones and accessories (29.5%), followed by VDOT platform infrastructure costs (21.7%), program support costs (19.5%), and internet data costs used by patients to send the videos (10.2%). The per-person costs of using VDOT are lower than the potential cost of daily transport that would be associated with facility-based DOT. Conclusion The implementation of VDOT in Kampala was associated with a relatively low cost compared to the projected cost when using the traditional DOT method. This highlights the cost saving benefit to the patients when using remote treatment monitoring with the video technology. A full economic evaluation from the programmatic and societal perspective is recommended to inform the adoption of the VDOT strategy in resource-limited settings.Keywords
All Related Versions
Funding Information
- National Institutes of Health (1R21 TW011365)
This publication has 28 references indexed in Scilit:
- Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic reviewBMJ Global Health, 2024
- HIV and tuberculosis in Uganda: are we neglecting poverty?The Lancet, 2024
- Asynchronous Video Directly Observed Therapy to Monitor Short-Course Latent Tuberculosis Infection Treatment: Results of a Randomized Controlled TrialOpen Forum Infectious Diseases, 2024
- Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in UgandaValue in Health, 2022
- A review of mobile health interventions for public private mix in tuberculosis careInternet Interventions, 2021
- Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods studyJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2019
- Quality of life and its effective factors in tuberculosis patients receiving directly observed treatment short-course (DOTS)Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2019
- Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research prioritiesBMJ Global Health, 2018
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisClinical Infectious Diseases, 2016
- Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural UgandaAIDS, 2016